Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

September 23, 2020

Siglec-15 as an emerging target for next-generation cancer immunotherapy

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jingwei SunJun Wang
September 25, 2020

A new potentiometric platform: Antibody cross-linked graphene oxide potentiometric immunosensor for clenbuterol determination

Biotechnology and Applied Biochemistry
Ebru Birlik ÖzkütükRıdvan Say
September 22, 2020
Review
Open Access

Immunotherapy in prostate cancer: current state and future perspectives

Therapeutic Advances in Urology
Shivani HandaAshutosh Tewari
September 22, 2020
Comment / Editorial
Open Access

Innate immune checkpoints for cancer immunotherapy: expanding the scope of non T cell targets

Annals of Translational Medicine
Luis F CampesatoTaha Merghoub
September 25, 2020

Autoantibody landscape in patients with advanced prostate cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
William S ChenFelix Y Feng
September 25, 2020

Sparse Linear Discriminant Analysis using the Prior-Knowledge-Guided Block Covariance Matrix

Chemometrics and Intelligent Laboratory Systems : an International Journal Sponsored by the Chemometrics Society
Jin Hyun NamDongjun Chung
September 22, 2020

Strategic aspects of NPY-based monoclonal antibodies for diagnosis and treatment of breast cancer

Current Protein & Peptide Science
Drashti Desai, Pravin Shende
September 24, 2020
Open Access

CIITA-transduced glioblastoma cells uncover a rich repertoire of clinically relevant tumor-associated HLA-II antigens

Molecular & Cellular Proteomics : MCP
Greta ForlaniMichal Bassani-Sternberg
September 23, 2020
Open Access

Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines

ACS Applied Materials & Interfaces
Ruoyu ChengHélder A Santos
September 22, 2020
Open Access

Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform

Computational and Structural Biotechnology Journal
Rita AhmedLana E Kandalaft
September 24, 2020

Synthetic Antibody Mimics Based on Cancer-Targeting Immunostimulatory Peptides

Chembiochem : a European Journal of Chemical Biology
Dante Descalzi-MontoyaDavid Sabatino
September 24, 2020
Open Access

Investigation of the frequency of COVID-19 in patients treated with intravesical BCG

Revista da Associação Médica Brasileira
Oğuz KarabayErtugrul Guclu
September 24, 2020
Review
Open Access

Progress of immune checkpoint LAG-3 in immunotherapy

Oncology Letters
Chanchan ShanJian Zhang
September 22, 2020

TEPI-2 and UBI: designs for optimal immuno-oncology and cell therapy dose finding with toxicity and efficacy

Journal of Biopharmaceutical Statistics
Pin LiYuan Ji
September 25, 2020

CD73 contributes to anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice

European Journal of Immunology
Dominik EichinSirpa Jalkanen
September 25, 2020
Review
Open Access

Targeting tumor-associated macrophages in the tumor microenvironment

Oncology Letters
Kaiwen ZhouMuying Ying

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2020 Meta ULC. All rights reserved
/feed-previews/cancer-vaccines/3a9aa425-500b-4672-a29a-0c14cd87a363